SFDA To Disclose Government Information
This article was originally published in PharmAsia News
China's State FDA will voluntarily disclose nine categories of government information including: organizational functions, personnel information, regulations and documents, announcements and notices, planning and programs, integration management, basic statistics, administrative permission and latest news. Citizens, legal entities and institutions may request such data from SFDA. Information such as quality bulletins, illegal drug advertisement notices, GMP and GSP authentication, adverse drug effects, tenders, key project approval and other details will be published at its website as well as via news conferences, newspapers, radio and TV to facilitate public access. The agency has officially started accepting such information requests since May 1. (Click here for more - Chinese Language)
You may also be interested in...
There is speculation that it is the end of the road for abicipar pegol but Allergan has declined to say whether this is the case for the product that has been in development for wet AMD.
In the EU, voices calling for a postponement of the IVD Regulation’s 2022 enforcement date are growing louder.
After talking with the FDA, Atox will file an NDA for its necrotizing soft tissue infections therapy despite missing primary endpoints in a pivotal trial, the biotech’s CEO tells Scrip.